THROMBOSIS
Clinical trials for THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new THROMBOSIS trials appear
Sign up with your email to follow new studies for THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood thinner showdown: which prevents clots best after heart procedure?
Disease control OngoingThis study tests whether 8 weeks of a blood thinner (DOAC) or antiplatelet medication works better to prevent clots on a device placed in the heart's left atrial appendage. The device is used to reduce stroke risk in people with atrial fibrillation. The trial involves 510 adults …
Matched conditions: THROMBOSIS
Phase: PHASE4 • Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Blood thinner safety in artery surgery under review
Knowledge-focused OngoingThis study looks at whether taking blood thinners (antiplatelets and anticoagulants) affects the risk of bleeding or clots during major artery surgery. Researchers will review the medical records of 500 patients who had non-cardiac vascular surgery. They want to see if stopping t…
Matched conditions: THROMBOSIS
Sponsor: Petrovsky National Research Centre of Surgery • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
Blood thinner users: is a 24-Hour hospital stay after a minor head bump really needed?
Knowledge-focused OngoingThis study looks at 600 adults who take blood thinners and have a mild head injury but a normal first brain scan. The goal is to find out how often a delayed brain bleed or other problems like blood clots or confusion happen within 24 hours to 4 weeks after the injury. The result…
Matched conditions: THROMBOSIS
Sponsor: Bispebjerg Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Blood thinner showdown: which test wins?
Knowledge-focused ENROLLING_BY_INVITATIONThis study compares two blood tests (PTT and anti-Xa) used to monitor the blood thinner heparin in hospitalized patients with blood clots. The goal is to see which test helps patients reach a safe and effective level of anticoagulation more quickly. About 700 adults at Vanderbilt…
Matched conditions: THROMBOSIS
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC